Anatomical and functional correlates in major depressive disorder: The contribution of neuroimaging studies

Several studies suggested the neural networks modulating aspects of emotional behaviour to be implicated in the pathophysiology of mood disorders. These networks involve the medial prefrontal cortex (MPFC) and closely related areas in the medial and caudolateral orbital cortex (medial prefrontal network), amygdala, hippocampus, and ventromedial parts of the basal ganglia, where alterations in grey matter volume and neurophysiological activity are found in cases with recurrent depressive episodes. Such findings hold major implications for models of the neurocircuits that underlie depression. In particular, evidence from lesion analysis studies suggests that MPFC and related limbic and striato-pallido-thalamic structures organize emotional expression. The aim of this paper is to review the contribution of the most relevant studies with single photon emission tomography (SPECT), positron emission tomography (PET) and magnetic resonance imaging (MRI) to the understanding of pathophysiology of major depressive disorder (MDD), with particular focus on the reversibility of functional correlates with treatment.

[1]  K. Saleem,et al.  Differential connections of the perirhinal and parahippocampal cortex with the orbital and medial prefrontal networks in macaque monkeys , 2005, The Journal of comparative neurology.

[2]  M. Lowe,et al.  Activity and Connectivity of Brain Mood Regulating Circuit in Depression: A Functional Magnetic Resonance Study , 2005, Biological Psychiatry.

[3]  S. Houle,et al.  Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. , 2001, The American journal of psychiatry.

[4]  L. Kessing,et al.  Epidemiology of subtypes of depression , 2007, Acta psychiatrica Scandinavica. Supplementum.

[5]  M. Karamouzis,et al.  Is it possible to predict the long-term response to venlafaxine with the use of biological markers and psychophysiological methods? , 2007, Journal of affective disorders.

[6]  Monte S. Buchsbaum,et al.  Effect of sertraline on regional metabolic rate in patients with affective disorder , 1997, Biological Psychiatry.

[7]  M. Abou-Saleh,et al.  Neuroimaging in psychiatry: An update. , 2006, Journal of psychosomatic research.

[8]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[9]  W. Bilker,et al.  Atrophy and High Intensity Lesions , 2000, Neuropsychopharmacology.

[10]  M E Phelps,et al.  Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. , 2001, Archives of general psychiatry.

[11]  J. Price,et al.  Architectonic subdivision of the human orbital and medial prefrontal cortex , 2003, The Journal of comparative neurology.

[12]  B Beuthien-Baumann,et al.  Changes in brain metabolism associated with remission in unipolar major depression , 2004, Acta psychiatrica Scandinavica.

[13]  H. Walter,et al.  Aberrant functional connectivity of dorsolateral prefrontal and cingulate networks in patients with major depression during working memory processing , 2008, Psychological Medicine.

[14]  J. Lurito,et al.  Correlations in Low-Frequency BOLD Fluctuations Reflect Cortico-Cortical Connections , 2000, NeuroImage.

[15]  J A Maldjian,et al.  Functional connectivity MR imaging: fact or artifact? , 2001, AJNR. American journal of neuroradiology.

[16]  F. McMahon,et al.  Genetic association studies in mood disorders: issues and promise. , 2004, International review of psychiatry.

[17]  M. Fava,et al.  A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity , 1998, Psychiatry Research: Neuroimaging.

[18]  L. Kessing,et al.  Attitudes and beliefs among patients treated with mood stabilizers , 2006, Clinical practice and epidemiology in mental health : CP & EMH.

[19]  M. Raichle,et al.  A functional anatomical study of unipolar depression , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  B. Grant,et al.  Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. , 2005, Archives of general psychiatry.

[21]  I. Hickie,et al.  Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression , 1999, Psychiatry Research: Neuroimaging.

[22]  Glenda M. MacQueen,et al.  Posterior Hippocampal Volumes Are Associated with Remission Rates in Patients with Major Depressive Disorder , 2008, Biological Psychiatry.

[23]  Angela R Laird,et al.  A meta‐analytic study of changes in brain activation in depression , 2008, Human brain mapping.

[24]  M. Furey,et al.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.

[25]  S. Alborzian,et al.  Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine , 1999, Psychiatry Research: Neuroimaging.

[26]  T. Croghan,et al.  Racial variation in antidepressant treatment in a Medicaid population. , 2000, The Journal of clinical psychiatry.

[27]  G. Pearlson,et al.  MRI findings differentiate between late‐onset schizophrenia and late‐life mood disorder , 2000, International journal of geriatric psychiatry.

[28]  M. Portella,et al.  Prognostic value of frontal functional neuroimaging in late-onset severe major depression , 2004, British Journal of Psychiatry.

[29]  M. Mimura,et al.  Changes in regional cerebral blood flow following antidepressant treatment in late‐life depression , 2008, International journal of geriatric psychiatry.

[30]  P. Jerabek,et al.  Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response , 2000, Biological Psychiatry.

[31]  A. Tutuş,et al.  The regional cerebral blood flow changes in major depressive disorder with and without psychotic features , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  D. Salmaso,et al.  Principal component and volume of interest analyses in depressed patients imaged by 99mTc-HMPAO SPET: a methodological comparison , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  P. Sullivan,et al.  Genetic epidemiology of major depression: review and meta-analysis. , 2000, The American journal of psychiatry.

[34]  H. Mayberg Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[35]  W. Drevets,et al.  The Subgenual Anterior Cingulate Cortex in Mood Disorders , 2008, CNS Spectrums.

[36]  I. Kwak,et al.  Statistical parametric mapping analysis of the relationship between regional cerebral blood flow and symptom clusters of the depressive mood in patients with pre-dialytic chronic kidney disease , 2008, Annals of nuclear medicine.

[37]  F. Fazio,et al.  Effects of Fluvoxamine Treatment on the in Vivo Binding of [F-18]FESP in Drug Naive Depressed Patients: A Pet Study , 2000, NeuroImage.

[38]  J. Amsterdam,et al.  HMPAO spect brain imaging in treatment-resistant depression , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[39]  Helen S Mayberg,et al.  Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. , 2002, The American journal of psychiatry.

[40]  K. Krishnan,et al.  In vivo stereological assessment of caudate volume in man: effect of normal aging. , 1990, Life sciences.

[41]  M. Ernst,et al.  fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. , 2009, Journal of affective disorders.

[42]  M. Thase,et al.  Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. , 2006, The American journal of psychiatry.

[43]  G Ratcliff,et al.  Cognitive correlates of human brain aging: a quantitative magnetic resonance imaging investigation. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[44]  Vincent A Magnotta,et al.  Hippocampal volume and 2-year outcome in depression. , 2008, The British journal of psychiatry : the journal of mental science.

[45]  D. Charney,et al.  Norepinephrine dysfunction in depression. , 2000, The Journal of clinical psychiatry.

[46]  M. Raichle,et al.  Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism , 2002, European Neuropsychopharmacology.

[47]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[48]  Gerd Wagner,et al.  Fronto-cingulate effective connectivity in major depression: A study with fMRI and dynamic causal modeling , 2008, NeuroImage.

[49]  Vinod Menon,et al.  Functional connectivity in the resting brain: A network analysis of the default mode hypothesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Komatani,et al.  Changes in regional brain activity in major depression after successful treatment with antidepressant drugs , 1998, Acta Psychiatrica Scandinavica.

[51]  Klaus P. Ebmeier,et al.  Mood and cerebral perfusion revisited. , 2000, Behavioural neurology.

[52]  R. Zipursky,et al.  PET and SPECT Imaging in Psychiatric Disorders , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[53]  Jayaram K. Udupa,et al.  Original articlesAtrophy and High Intensity Lesions: Complementary Neurobiological Mechanisms in Late-Life Major Depression , 2000 .

[54]  P. Fox,et al.  Cingulate function in depression: a potential predictor of treatment response , 1997, Neuroreport.

[55]  Nanette Freedman,et al.  99mTc-HMPAO SPECT Study of Cerebral Perfusion After Treatment with Medication and Electroconvulsive Therapy in Major Depression , 2007, Journal of Nuclear Medicine.

[56]  Karl J. Friston,et al.  Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions , 1993, Psychological Medicine.

[57]  M. Kocmur,et al.  Evaluation of brain perfusion with technetium-99m bicisate single-photon emission tomography in patients with depressive disorder before and after drug treatment , 1998, European Journal of Nuclear Medicine.

[58]  A. Graff-Guerrero,et al.  Correlation between cerebral blood flow and items of the Hamilton Rating Scale for Depression in antidepressant-naive patients. , 2004, Journal of affective disorders.

[59]  J. Mazziotta,et al.  Reduction of prefrontal cortex glucose metabolism common to three types of depression. , 1989, Archives of general psychiatry.

[60]  M Ashtari,et al.  Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease? , 1997, Psychological Medicine.

[61]  Mario Dzemidzic,et al.  Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression , 2009, Psychiatry Research: Neuroimaging.

[62]  M. Yücel,et al.  Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. , 2009, Journal of affective disorders.

[63]  P. Jerabek,et al.  The functional neuroanatomy of the placebo effect. , 2002, The American journal of psychiatry.

[64]  C. Buchpiguel,et al.  Association between major depressive symptoms in heart failure and impaired regional cerebral blood flow in the medial temporal region: a study using 99mTc-HMPAO single photon emission computerized tomography (SPECT) , 2006, Psychological Medicine.

[65]  N. Kato,et al.  Metabolic changes in the brain of patients with late-onset major depression , 2008, Psychiatry Research: Neuroimaging.

[66]  I. Aharon,et al.  Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses , 2003, Psychiatry Research: Neuroimaging.

[67]  S. Kennedy,et al.  Neuroimaging approaches in mood disorders: technique and clinical implications. , 2007, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[68]  R. Marchbanks Choline, acetylcholine and dementia , 1980, Psychological Medicine.

[69]  K. Saleem,et al.  Complementary circuits connecting the orbital and medial prefrontal networks with the temporal, insular, and opercular cortex in the macaque monkey , 2008, The Journal of comparative neurology.

[70]  P. Skudlarski,et al.  Detection of functional connectivity using temporal correlations in MR images , 2002, Human brain mapping.

[71]  B. Lerer,et al.  Cerebral perfusion after a 2-year remission in major depression. , 2008, The international journal of neuropsychopharmacology.

[72]  D. Kupfer,et al.  Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.

[73]  M. Lowe,et al.  Antidepressant Effect on Connectivity of the Mood-Regulating Circuit: An fMRI Study , 2005, Neuropsychopharmacology.

[74]  K. Krishnan,et al.  Magnetic-resonance morphometry in patients with major depression , 1998, Psychiatry Research: Neuroimaging.

[75]  Francisco Lomeña,et al.  Normalization of Frontal Cerebral Perfusion in Remitted Elderly Major Depression: A 12-Month Follow-Up SPECT Study , 2002, NeuroImage.

[76]  J R Moeller,et al.  Regional cerebral blood flow in mood disorders. I. Comparison of major depressives and normal controls at rest. , 1990, Archives of general psychiatry.

[77]  Klaus P. Ebmeier,et al.  State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. , 1993, Journal of affective disorders.

[78]  Christian Büchel,et al.  Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter , 2005, Nature Neuroscience.

[79]  N. Werner,et al.  Functional MRI study of memory-related brain regions in patients with depressive disorder. , 2009, Journal of affective disorders.

[80]  Sung-Cheng Huang,et al.  Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. , 2002, Archives of general psychiatry.

[81]  A. Gonul,et al.  Volumetric MRI studies of the hippocampus in major depressive disorder: Meanings of inconsistency and directions for future research. , 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[82]  Karl J. Friston,et al.  Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations , 2002, Biological Psychiatry.

[83]  Wolfgang Maier,et al.  Response-dependent differences in regional cerebral blood flow changes with citalopram in treatment of major depression. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[84]  Almut Engelien,et al.  Working‐memory fMRI reveals cingulate hyperactivation in euthymic major depression , 2009, Human brain mapping.

[85]  Sati Mazumdar,et al.  Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression , 2004, Neuropsychopharmacology.

[86]  R. Belmaker,et al.  Major depressive disorder. , 2008, The New England journal of medicine.

[87]  K. Krishnan,et al.  A magnetic resonance imaging study of putamen nuclei in major depression , 1991, Psychiatry Research: Neuroimaging.

[88]  Martin P Paulus,et al.  Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. , 2008, Journal of affective disorders.

[89]  Karl J. Friston,et al.  Functional Connectivity: The Principal-Component Analysis of Large (PET) Data Sets , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[90]  C. Gastó,et al.  Frontal Cerebral Perfusion Dysfunction in Elderly Late-Onset Major Depression Assessed by 99MTC-HMPAO Spect , 2001, NeuroImage.

[91]  Robert L. Royall,et al.  Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. , 2001, Archives of general psychiatry.

[92]  A. Barnes,et al.  Changes in regional cerebral blood flow with venlafaxine in the treatment of major depression. , 2003, The American journal of psychiatry.

[93]  J. O'Brien,et al.  Structural Neuroimaging Studies in Late-Life Depression: A Review , 2001, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[94]  Andrei G. Vlassenko,et al.  Cerebral perfusion response to successful treatment of depression with different serotoninergic agents. , 2004, The Journal of neuropsychiatry and clinical neurosciences.

[95]  A L Brody,et al.  Prefrontal-subcortical and limbic circuit mediation of major depressive disorder. , 2001, Seminars in clinical neuropsychiatry.

[96]  Sidney H. Kennedy,et al.  Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. , 2007, The American journal of psychiatry.

[97]  G. MacQueen,et al.  A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[98]  Wayne C. Drevets,et al.  Depression, Mania, and Related Disorders. , 2005 .

[99]  Griselda J. Garrido,et al.  Psychotic symptoms in major depressive disorder are associated with reduced regional cerebral blood flow in the subgenual anterior cingulate cortex: a voxel-based single photon emission computed tomography (SPECT) study. , 2002, Journal of affective disorders.